approval
saveTECENTRIQ (ATEZOLIZUMAB) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- phase 2 completionArcus Biosciences Inc — atezolizumab (Phase II Trial Completion)Apr 30, 2026 · 154d ago
- phase 0 trial completionDana-Farber Cancer Institute Inc — atezolizumab (Phase 0 Trial Completion)Apr 29, 2026 · 155d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalNov 17, 2025 · 318d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalOct 2, 2025 · 364d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalApr 22, 2024 · 892d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 12, 2023 · 1238d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 12, 2023 · 1238d ago
- approvalTECENTRIQ (ATEZOLIZUMAB) — FDA approvalDec 9, 2022 · 1392d ago
same company · ±60 days · 6
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalAug 18, 2025
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalAug 8, 2025
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalAug 8, 2025
- approvalinavolisib: ITOVEBI (INAVOLISIB) — FDA approvalSep 25, 2025
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalOct 2, 2025
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalOct 2, 2025
🐶 often sniffed alongside
top 8- drugTECENTRIQ178 co-mentions · 46 sources
- tagApproval176 co-mentions · 44 sources
- companyGenentech Inc88 co-mentions · 44 sources
- drugTECENTRIQ HYBREZA20 co-mentions · 5 sources
- drug(atezolizumab + hyaluronidase (human recombinant))10 co-mentions · 5 sources
- tagOncology5 co-mentions · 2 sources
- companyDana-Farber Cancer Institute Inc1 co-mentions · 1 sources
- tagHepatology1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that